Actavis

Fosaprepitant

View Prices
  1. Home
    2.  / 
  2. J Code
    3.  / Fosaprepitant – J1456

Manufacturer:

Actavis

Name:

Fosaprepitant

HCPCS Code Descriptor:

Injection, fosaprepitant (teva), not therapeutically equivalent to j1453, 1 mg

Category:

J Code

HCPCS:

J1456

NDC(s):

00591-4385-79

Primary Type:

Oncology-Anti-Emetic

Generic Status:

Single-Source

Route of Administration:

Intravenous

About:

Fosaprepitant is an Oncology-Anti-Emetic drug manufactured by Actavis and administered via the Intravenous route of administration. The J Code: J1456 is aligned to the drug Fosaprepitant.

View Prices

Access Pricing and More By Registering

Register Now

HCPCS Added Date:

1/1/23

HCPCS Effective Date:

1/1/23

HCPCS Short Description:

Inj, fosaprepitant (teva)

Billing and Coding Guide:

Not Found

Patient Assistance:

Not Found